Intravitreal bevacizumab for delayed radiation maculopathy and papillopathy after irradiation for maxillary sinus cancer
Miki Gondo1, Tsutomu Sakai1, Hiroshi Tsuneoka1, Chihiro Kanehira21Department of Ophthalmology, Jikei University School of Medicine, 2Division of Radiology, Jikei University School of Medicine, Tokyo, JapanBackground: The evaluation of intravitreal bevacizumab treatment for delayed radiation maculopa...
Guardado en:
Autores principales: | Gondo M, Sakai T, Tsuneoka H, Kanehira C |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5227cc382474f8ebf9f507187229834 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity
por: Shah NV, et al.
Publicado: (2012) -
Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
por: Kim M, et al.
Publicado: (2013) -
Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma
por: Shah NV, et al.
Publicado: (2013) -
Central serous papillopathy by optic nerve head drusen
por: Ana Marina Suelves, et al.
Publicado: (2010) -
Case of endophthalmitis following intravitreal injections of bevacizumab
por: Shinya Komori, et al.
Publicado: (2010)